StockNews.com cut shares of Edap Tms (NASDAQ:EDAP – Free Report) from a hold rating to a sell rating in a research note issued to investors on Tuesday.
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a report on Thursday, August 29th.
Get Our Latest Stock Analysis on Edap Tms
Edap Tms Trading Up 1.2 %
Edap Tms (NASDAQ:EDAP – Get Free Report) last issued its earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The firm had revenue of $16.97 million during the quarter, compared to the consensus estimate of $17.16 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. On average, sell-side analysts anticipate that Edap Tms will post -0.6 earnings per share for the current fiscal year.
Institutional Trading of Edap Tms
Several hedge funds have recently bought and sold shares of EDAP. Redhawk Wealth Advisors Inc. purchased a new stake in Edap Tms in the 3rd quarter worth $36,000. BNP Paribas Financial Markets lifted its stake in Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after purchasing an additional 4,400 shares in the last quarter. Virtu Financial LLC purchased a new stake in Edap Tms in the 1st quarter worth $82,000. Orion Capital Management LLC lifted its stake in Edap Tms by 10.4% in the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after purchasing an additional 6,600 shares in the last quarter. Finally, Commonwealth Equity Services LLC lifted its stake in Edap Tms by 5.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock worth $388,000 after purchasing an additional 4,000 shares in the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
Further Reading
- Five stocks we like better than Edap Tms
- Low PE Growth Stocks: Unlocking Investment Opportunities
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Profitably Trade Stocks at 52-Week Highs
- 3 Penny Stocks Ready to Break Out in 2025
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.